1. Home
  2. IMXI vs CCCC Comparison

IMXI vs CCCC Comparison

Compare IMXI & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

HOLD

Current Price

$14.99

Market Cap

469.3M

Sector

Technology

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.90

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMXI
CCCC
Founded
1994
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.3M
404.7M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
IMXI
CCCC
Price
$14.99
$3.90
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$15.00
$12.20
AVG Volume (30 Days)
446.4K
2.3M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.45
EPS
0.02
N/A
Revenue
$319,601,000.00
$35,947,000.00
Revenue This Year
$0.83
N/A
Revenue Next Year
$1.49
N/A
P/E Ratio
$744.00
N/A
Revenue Growth
16.68
1.02
52 Week Low
$8.58
$1.36
52 Week High
$15.95
$4.60

Technical Indicators

Market Signals
Indicator
IMXI
CCCC
Relative Strength Index (RSI) 42.31 56.80
Support Level $14.86 $2.17
Resistance Level $15.19 $4.60
Average True Range (ATR) 0.23 0.40
MACD -0.00 -0.04
Stochastic Oscillator 52.86 42.33

Price Performance

Historical Comparison
IMXI
CCCC

About IMXI International Money Express Inc.

International Money Express Inc is an omnichannel money remittance services company focused on the United States of America to Latin America and the Caribbean corridor, which includes Mexico, Central and South America and the Caribbean. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: